Phillips Recalls StaphWash Skin Protectant Due to Manufacturing Deviations
Phillips Co. is recalling StaphWash+Plus+ Skin Protectant because FDA inspections found manufacturing practices that question the product's safety and quality.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II, which corresponds to a 'Severe' severity score under the rubric for significant manufacturing deviations affecting product safety and quality.
Plain-English summary
Phillips Co. is recalling StaphWash+Plus+ Skin Protectant, a zinc acetate solution in 0.3 fl. oz. bottles. The recall involves 10 to 30 units distributed nationwide and in the United Kingdom. All lots remaining within their expiration dates are affected.
The U.S. Food and Drug Administration (FDA) initiated this recall after an inspection identified significant Good Manufacturing Practice (GMP) deviations. These manufacturing practices call into question the safety, identity, strength, quality, and purity of the unexpired drug products manufactured by the firm.
Consumers should stop using the product and return it to the point of purchase or contact Phillips Co. for instructions on disposal or refund.
The recalled product
- Product
- StaphWash+Plus+ Skin Protectant, Zinc acetate (.1% by volume), 0.3 fl. oz. (3 mL) bottle, Phillips Company, Millerton, OK -- NDC 43074-101-01
- Manufacturer
- Phillips Co.
- Category
- Drug — Topical Antiseptic
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- All lots remaining within expiry.
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 6 recalled by Phillips Co. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 6 products in this recall →Related recalls
Same manufacturer · Phillips Co.
See all →- SevereTetraStem Topical Antibiotic Ointment Recalled for Manufacturing Deviations
FDA (Drugs) · 2017-07-12
- SeverePhillips Co. Recalls StingMed Insect Bites Skin Protectant Due to GMP Deviations
FDA (Drugs) · 2017-07-12
- SeverePhillips Tetracycline Ointment Recalled for Manufacturing Quality Concerns
FDA (Drugs) · 2017-07-12
- SeverePhillips Co. Recalls VenomX Zinc Acetate Skin Protectant Due to GMP Deviations
FDA (Drugs) · 2017-07-12
- SeverePhillips Recalls Diabecline Topical Ointment Due to Manufacturing Deviations
FDA (Drugs) · 2017-07-12
Same hazard · gmp deviation
See all →- HighPrazosin hydrochloride tablets recalled over nitrosamine impurity above limits
FDA (Drugs) · 2026-04-08
- HighPrazosin hydrochloride further lots recalled over nitrosamine impurity levels
FDA (Drugs) · 2026-04-08
- HighPrazosin hydrochloride 100-count bottles recalled over nitrosamine impurity
FDA (Drugs) · 2026-04-08
- ModerateFirst Aid Only hand sanitizing wipes recalled over manufacturing deviations
FDA (Drugs) · 2026-03-11
- ModerateFirst Aid Only BZK antiseptic towelettes recalled over manufacturing deviations
FDA (Drugs) · 2026-03-11
Similar recalls
- SevereUS Compounding Recalls Zinc Sulfate Vials Due to Sterility Concerns
FDA (Drugs) · 2015-11-25
- ModerateUS Pharmaceuticals Recalls Soothe & Cool Protect Moisture Guard Skin Protectant
FDA (Drugs) · 2019-02-13
- ModerateWipesPlus alcohol free BZK wipes recalled over manufacturing practice deviations
FDA (Drugs) · 2026-03-11
- HighFDA Recalls Omeza Skin Protectant Gel Due to Manufacturing Deviations
FDA (Drugs) · 2024-02-14
- SevereZinc Injectable Recalled Due to Sterility Assurance Concerns
FDA (Drugs) · 2015-09-23
- ModerateUS Pharmaceuticals Recalls Soothe&Cool Protect Moisture Guard Skin Protectant
FDA (Drugs) · 2019-08-21